Why the study?
Does the -455G/A polymorphism or preprocedural fibrinogen level predict the risk of clinical restenosis in patients with coronary stent placement?
Population
3,146 consecutive patients after successful percutaneous coronary intervention, of which 2,309 received a…
Comparison
Presence of -455G/A polymorphism in the… vs Absence of the -455G/A polymorphism and lowest…
Design
Cohort
Authors
Loading...
Should not guide pre-stenting risk stratification with -455G/A or fibrinogen; leaves open identification of other restenosis predictors.
Does the -455G/A polymorphism or preprocedural fibrinogen level predict the risk of clinical restenosis in patients with coronary stent placement?
The -455G/A polymorphism and preprocedural fibrinogen levels do not predict clinical restenosis after coronary stenting and are not useful for pre-stenting risk stratification.
Monraats et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: